Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
Colon cancer is often associated with the mammalian target of rapamycin (mTOR), a serine/threonine kinase activated in a range of cellular ... Read more
A statistical-based computer model created by two scientists at the Johns Hopkins Kimmel Cancer Center places colon cancer in the category ... Read more
An “excellent” study–defined as such by meeting the randomized controlled trial requirement of Level I Evidence in medicine–from the Fox Chase ... Read more
An effective new therapy used against bowel cancer tumors may be quickly propelled from laboratory testing to clinical trials for subsequent approval. ... Read more
